Hamm John M. 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed Mar 27, 2023
Insider Transaction Report
Form 4
Hamm John M.
Chief Financial Officer
Transactions
- Award
Options (right to buy)
2023-03-24+2,000→ 7,000 totalExercise: $1.97From: 2027-03-24Exp: 2033-03-24→ Common Stock (2,000 underlying)
Footnotes (1)
- [F1]100% vesting on March 24, 2027.